Predicting the Histological Type of Spinal Metastases Using Amide Proton Transfer-Weighted Imaging Combined with Apparent Diffusion Coefficient

When cancer spreads from its original site to the bones of the spine, it creates a complex medical puzzle. These secondary tumors, known as metastases, can cause severe pain and limit movement, but the most critical challenge for doctors is often simply knowing where the cancer began. A tumor that started in the lung behaves differently than one that started in the breast or the prostate, and the treatment plans for each are entirely distinct. To make the right choice, physicians usually need to know the specific type of cancer, but finding that answer often requires an invasive biopsy, a procedure that carries risks and can be difficult to perform on the spine. For years, standard magnetic resonance imaging, or MRI, has been the go-to tool for viewing these lesions, offering clear pictures of where the tumor is and how large it has grown. However, these traditional images mostly show the shape and size of the mass, leaving the internal biological makeup of the tumor a mystery. They can see the forest, but they struggle to identify the specific species of tree.

To solve this, researchers at the Affiliated Hospital of Gansu University of Chinese Medicine turned to two advanced imaging techniques that look deeper than the surface. The first is a method called amide proton transfer-weighted imaging, which acts like a chemical sensor. It detects the presence of mobile proteins and peptides within the tumor tissue by tracking how certain hydrogen atoms exchange with water molecules. Because different types of cancer cells produce different amounts of proteins and have different metabolic activities, this technique can reveal a chemical signature unique to the tumor's origin. The second technique is the apparent diffusion coefficient, a measurement derived from diffusion-weighted imaging that maps how freely water molecules move through the tissue. In tightly packed, fast-growing tumors, water struggles to move, while in looser tissues, it flows more easily. By combining these two views—one looking at the chemical composition and the other at the physical density of the cells—the researchers hoped to create a more complete picture of the tumor's identity without needing a needle.

The team conducted a prospective study involving sixty-one patients who had already been confirmed through pathology to have spinal metastases. The group was divided into three categories based on the primary source of their cancer: twenty patients with lung cancer, twenty-six with prostate cancer, and fifteen with breast cancer. Each patient underwent a comprehensive MRI scan that included standard sequences, the chemical-sensitive amide proton transfer imaging, and the diffusion-weighted imaging. Three experienced radiologists, who did not know the patients' final diagnoses, independently measured the values from the solid parts of the tumors on the images. They carefully drew regions of interest around the tumor masses, avoiding areas of dead tissue or fluid to ensure they were measuring only the active cancer cells. The researchers found that the measurements were highly consistent between the different doctors, confirming that the technique was reliable.

When the data was analyzed, clear differences emerged between the three groups. The lung cancer metastases showed the highest chemical signal from the amide proton transfer imaging, averaging nearly five percent. The prostate cancer metastases fell in the middle, while the breast cancer metastases showed the lowest values, averaging just over three percent. This suggested that lung cancer cells in the spine were producing more mobile proteins or had a different metabolic environment than the other two types. The water movement measurements told a slightly different story. The prostate cancer group showed the highest values for water diffusion, meaning water moved more freely through those tumors compared to the lung and breast cancer groups. Interestingly, the water movement in the lung and breast cancer groups was quite similar, making it harder to tell them apart using that single measurement alone.

To see how well these numbers could actually tell the cancers apart, the researchers used a statistical method to test their accuracy. When trying to distinguish lung cancer from prostate cancer, using the chemical signal alone was helpful, but combining it with the water movement data improved the accuracy significantly. The combined approach was even more effective at separating prostate cancer from breast cancer. However, when it came to telling lung cancer apart from breast cancer, the chemical signal was already so powerful on its own that adding the water measurement did not add much extra value. The study concluded that while neither technique is perfect on its own for every comparison, using them together provides a powerful, non-invasive way to predict the origin of spinal metastases. This approach offers a new layer of information that could help doctors tailor treatment plans more quickly and safely, potentially reducing the need for risky biopsies in difficult cases.